Table V.
The four metabolites showed significant difference between the OSCC patients’ per- and postoperative plasma samples using the Wilcoxon signed-rank test (P < 0.05)
| OSCC | Post-operation/Pre-operation | p-value |
|---|---|---|
| Nonanoic acid | 0.66 | 0.0008 |
| Glucose | 1.59 | 0.0008 |
| Galactose | 1.39 | <0.0001 |
| Cysteine+Cystine | 0.61 | <0.0001 |
| OD | Post-operation/Pre-operation | p-value |
|---|---|---|
| Nonanoic acid | 0.84 | 0.2554 |
| Glucose | 1.46 | <0.0001 |
| Galactose | 1.09 | 0.2179 |
| Cysteine+Cystine | 1.12 | 0.1000 |
The selected four biomarker candidates were also significantly different between the OSCC patients’ per- and postoperative plasma sample using the Wilcoxon signed-rank test (P < 0.05).